Interferon-β reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects

Immunology

Volumn 122, Issue 4, 2007, Pages 562-570

  Tanabe, Junichi ^a   Izawa, Akiko ^a   Takemi, Natsumi ^a   Miyauchi, Yasushi ^b   Torii, Yuichi ^a   Tsuchiyama, Hiromi ^a   Suzuki, Tomohiko ^a   Sone, Saburo ^a   Ando, Kazuki ^c  

^a TORAY INDUSTRIES INC   (Japan)

^b Kamakura Techno Science Inc   (Japan)

^c Goto Clinic   (Japan)

Author keywords

Cirrhosis; Concanavalin A; Fibrosis; Hepatitis; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; BASIC FIBROBLAST GROWTH FACTOR; BETA INTERFERON; COLLAGEN TYPE 1; CONCANAVALIN A; HYDROXYPROLINE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; COLLAGEN; CONCANAVALIN A; CYTOKINES; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; FEMALE; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HEMOSTASIS; HYDROXYPROLINE; INTERFERON TYPE I, RECOMBINANT; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 35948958265     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02672.x     Document Type: Article

References (48)

1. Kobayashi K, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C. A comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996 23: 695 9.
2. Yano M, Kumada H, Kaga M et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996 23: 1334 40.
3. Ikeda F, Shimomura H, Miyake M et al. Early clearance of circulating hepatitis C virus enhanced by induction therapy with twice-a-day intravenous injection of IFN-beta. J Interferon Cytokine Res 2000 20: 831 6.
4. Izumi N, Kumada H, Hashimoto N, Harada H, Imawari M, Zeniya M, Toda G. Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study. Dig Dis Sci 2001 46: 516 23.
5. Nomura H, Sou S, Nagahama T, Hayashi J, Kashiwagi S, Ishibashi H. Efficacy of early retreatment with interferon beta for relapse in patients with genotype Ib chronic hepatitis C. Hepatol Res 2004 28: 36 40.
6. Alric L, Duffaut M, Selves J et al. Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial. J Hepatol 2001 35: 272 8.
7. Omata M, Shiratori Y. Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C. J Gastro Hepatol 2005 15 (Suppl. E134 40.
8. Suou T, Hosho K, Kishimoto Y, Horie Y, Kawasaki H. Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alpha. Hepatology 1995 22: 426 31.
9. Hiramatsu N, Hayashi N, Kasahara A et al. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. J Hepatol 1995 22: 135 42.
10. Kimura K, Ando K, Ohnishi H, Ishikawa T, Kakumu S, Takemura M, Muto Y, Moriwaki H. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. Int Immunol 1999 11: 1491 500.
11. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961 93: 440 7.
12. Miyazawa Y, Tsutsui H, Mizuhara H, Fujiwara H, Kanda K. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Hepatology 1997 27: 497 506.
13. Elias JA, Jimenez SA, Freundlich B. Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am Rev Respir Dis 1987 135: 62062 5.
14. Stephenson ML, Krane SM, Amento EP, McCroskery PA, Byrne M. Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs. FEBS Lett 1995 180: 43 50.
15. Azuma A, Li YJ, Abe S et al. Interferon-beta inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-beta and thrombospondin. Am J Respir Cell Mol Biol 2005 32: 93 8.
16. Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005 436: 946 52.
17. Milani S, Herbst H, Schuppan D, Hahan EG, Stein HA. In situ hybridization for procollagen types I, III and VI Mrna in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology 1989 10: 84 92.
18. Rubin E, Hutterer F, Popper H. Experimental hepatic fibrosis without hepatocellular regeneration. A kinetic study. Am J Pathol 1968 52: 111 20.
19. Milani S, Herbst H, Schuppan D, Kim KY, Riecken EO, Stein H. Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology 1990 98: 175 84.
20. Fort J, Pilette C, Veal N, Oberti F, Gallois Y, Douay O, Rosenbaum J, Cales P. Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats. J Hepatol 1998 29: 263 70.
21. Tarcin O, Avsar K, Demirturk L et al. In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity. J Gastroenterol Hepatol 2003 18: 437 44.
22. Inagaki Y, Nemoto T, Kushida M et al. Interferon alpha down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 2003 38: 890 9.
23. Tiegs G, Hentschel J, Wendel AA. T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992 90: 196 203.
24. Takeda K, Hayakawa Y, Kaer LV, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000 97: 5498 503.
25. Gantner F, Leist M, Lohse AW, Germann PG, Tieg G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995 21: 190 8.
26. Mizuhara H, Uno M, Seki N et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996 23: 1608 15.
27. + T cells for concanavalin A-induced hepatic injury in mice. J Immunol 1997 159: 1537 42.
28. Muraro PA, Liberati L, Bonanni L et al. Decreased integrin gene expression in patients with MS responding to interferon-β treatment. J Neuroimmunol 2004 150: 123 31.
29. Gniadek P, Aktas O, Wandinger KP et al. Systemic IFN-β treatment induces apoptosis of peripheral immune cells in MS patients. J Neuroimmunol 2003 137: 187 96.
30. 1b leads to a short-term increase of soluble but long-term stabilization of cell surface bound adhesion molecules in multiple sclerosis. J Neurol 2004 251: 464 72.
31. Zang YC, Yang D, Hong J, Tejada-Simon V, Rivera V, Zhang JZ. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology 2000 55: 397 404.
32. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994 269: 14828 34.
33. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000 275: 2247 50.
34. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995 22 (Suppl. 28 36.
35. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996 110: 821 31.
36. Olaso E, Friedman SL. Molecular regulation of hepatic fibrosis. J Hepatol 1998 29: 836 47.
37. Iredale JP, Benyon RC, Arthur MJ, Ferris WT, Alcolado R, Winwood PJ, Clark N, Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996 24: 176 84.
38. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998 192: 538 49.
39. Rosenbaum J, Blazejewski S, Preaux AM, Mallat A, Dhumeaux D, Mavier P. Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts. Gastroenterology 1995 109: 1986 96.
40. Ajuebor MN, Hogaboam CM, Le T, Proudfoot AE, Swain MG. CCL3/MIP-1alpha is proinflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver. Eur J Immunol 2004 34: 2907 18.
41. Gantner F, Leist M, Kusters S, Vogt K, Volk HD, Tiegs G. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res 1996 229: 137 46.
42. Morikawa H, Hachiya K, Mizuhara H, Fujiwara H, Nishiguchi S, Shiomi S, Kuroki T, Kaneda K. Sublobular veins as the main site of lymphocyte adhesion/transmigration and adhesion molecule expression in the porto-sinusoidal-hepatic venous system during concanavalin A-induced hepatitis in mice. Hepatology 2000 31: 83 94.
43. Massaguer A, Perez-del-Pulgar S, Engel P, Serratosa J, Bosch J, Pizcueta P. Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin. J Leuko Biol 2002 72: 262 70.
44. Neumann B, Machleidt T, Lifka A, Pfeffer K, Vestweber D, Mak TW, Holzmann B, Kronke M. Crucial role of 55-kilodalton TFN receptor in TNF-induced adhesion molecular expression and leukocyte organ infiltration. J Immunol 1996 156: 1587 93.
45. Conway JG, Popp JA, Thurman RG. Microcirculation in periportal and pericentral regions of lobule in perfused rat liver. Am J Physiol 1985 249: G449 56.
46. Todoroki N, Watanabe Y, Akaike T et al. Enhancement of IL-1β and IFN-γ of platelet activation. Adhesion to leukocytes via GMP-140/PADGEM protein (CD62). Biochem Biophys Res Commun 1991 179: 756 61.
47. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990 50: 537 44.
48. Miller A, Lanir N, Shapiro S, Revel M, Honiqman S, Kinarty A, Lahat N. Immunoregulatory effects of IFN-β and interacting cytokines on human vascular endothelial cells. J Neuroimmunol 1996 64: 151 61.